(1)
HANDAYANI, F.; FITRIA, N.; SARI, Y. O.; A., A. IMPACT OF THE COMBINATION OF DOXORUBICIN, CYCLOPHOSPHAMIDE, AND DOCETAXEL ON CA 15-3 BIOMARKER LEVELS IN BREAST CANCER PATIENTS: A COMPARATIVE STUDY BETWEEN DELAYED AND NON-DELAYED CHEMOTHERAPY. Int J App Pharm 2025, 17, 82-88.